Skip to main content
Adagrasib shows durable benefit in KRAS-mutated NSCLC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Adagrasib shows durable benefit in KRAS-mutated NSCLC
User login
Username
Password
Reset your password
Concept
Lead
score
Lung Cancer
1
1
Non-Small Cell Lung Cancer
0
0.68
KRAS
0
0.65
Central Nervous System
0
0.47
Metastasis
0
0.42
Toxicology
0
0.21
Cancer
0
0.18
Chemotherapy
0
0.12
Food and Drug Administration (FDA)
0
0.12
Lung
0
0.12
Clinical Research
0
0.06
Platinum
0
0.06
Tumor
0
0.06
Specialty
Lead
score
Hematology-Oncology
1
1
Neurology & Neurosurgery
0
1
Pharmacist
0
0.54
Public Health & Prevention
0
0.24
Emergency Medicine
0
0.21
Edit Tags